Only 26 of 84 funding announcements named a single customer

Only 26 of 84 funding announcements named a single customer

EliseAI's announcement of 29 September is a good place to start, because it is complete in one way and empty in several others. The company says it raised $350 million at a $4 billion valuation, led by Andreessen Horowitz and Bessemer, and that its software reaches 6.5 million apartment units with annual recurring revenue above $200 million. It does not name the stage of the round. It says only that the money "gives us the ability to move faster", so there is no spending plan. It names no executive, quotes no investor and publishes no price. Our item on the round says so in plain terms. A buyer learns what the company thinks it is worth and very little that can be tested.

We went back through the 84 funding-news items we published between 2 and 9 October 2026 and counted what each announcement let a buyer check. Seventy-three named a lead investor or the only investor. Sixty-three stated a stage. Six carried a valuation that the company itself gave. Forty-eight gave a customer, revenue, usage or results figure, and in none of those 48 did our item record anyone other than the company or its investors vouching for it. Twenty-six named a customer. Fifty-one needed a red note.

This counts what 84 of our own items recorded. Where an item did not say something, we counted it as not stated, even if the company says it elsewhere.

The count, item by item

What a buyer could check	Items that said it	Items that did not
Lead investor, or the only investor, named	73	11
Other investors named	69	15
Stage stated (seed, Series A and so on)	63	21
One amount stated for the round	76	8
Valuation stated by the company	6	78
What the money is for	78	6
Customer, revenue, usage or results figure	48	36
That figure confirmed by someone other than the company or its investors	0	48
At least one customer named	26	58
Founding year, an earlier round or total raised	57	27
Company's country stated	78	6
First source was the company's own site	56	28
Red note needed	51	33

Forty-nine of the 84 items gave the four basics together: a lead or sole investor, a stage, an amount and a use for the money. Fifty-nine named both a lead and other investors. No item filled every row, because the confirmation row is empty for all of them. The confirmation row counts only the 48 items that carried a figure.

Eleven announcements named no lead and 21 gave no stage

A lead investor usually sets the terms and does the diligence, so it is the first name a buyer looks for. Eleven items did not give one. Ten of those still named at least one investor. Reco announced a strategic investment from AT&T Ventures and two new investors without saying who led. Flyle listed nine investors and the release does not say who led the round. Vinci showed its investors only as logos on its website and its post does not say who led. Healthleap named three funds and no leader. Only DriveX named none, describing its backers as operating companies and individual investors.

Stage is where announcements go quiet most often. Twenty-one items left it out, and 17 of those carry a red note. Kuro and its lead investor both say "funding round" and give no stage. Clockwork.io is a sharper case: the press called its round a Series C, the company's own wording did not, and we left the stage out of the headline. Supabase named no stage either, and said part of the money gives employees liquidity, which means not all of it went to the business. Manus published a post of three sentences with an amount of "over $500 million" and no stage.

Naming a stage can also mislead. knewit called its round a pre-Series A, but the company announced a pre-Series A in 2024 as well, so the label does not tell a buyer which round this is. Deepslate's stage came from the Tech.eu report alone.

Amounts, valuations and debt inside the headline number

Seventy-six items gave one amount for the round. Eight did not, each in its own way. knewit gave only cumulative funding. Prodoc AI said the amount was undisclosed. The two outlets covering Unveilr AI disagreed with each other. Trustly announced signed commitments of more than USD 40 million toward a capital raise that was due to conclude in November, so the final figure did not exist yet. FRANK reported "total investment", which may include earlier money. Manus gave a floor. Promenaut gave total funding rather than a round. AIBORN gave no amount for a strategic investment from Medical Data Vision.

Valuations are rarer still. The company gave one in six items: Snorkel AI, Island, Armadin, PaleBlueDot AI, EliseAI and Vinci. In four more, a valuation appeared only in the press. Brahma AI gave none in its release and Inc42 reported one. TechCrunch gave one for Arena, Entrackr for Unveilr AI, and TechCrunch reported talks about one for Manus that the company has not confirmed. A valuation that only a reporter supplies cannot be tied to the deal's terms.

Not every amount is equity. Four items included debt, a grant or both. Henry raised ¥1.2 billion, of which the company says ¥1.1 billion is a syndicated loan from five regional banks and ¥100 million is equity; the release gives no repayment terms. GMI Cloud announced a Series B alongside a separate credit facility and counted the two together as new funding, with the debt reported only on its own blog. AIONA combined convertible equity and bank loans and did not say how much was borrowed. hexafarms closed a seed round and also took a start-up grant and a subordinated loan of up to €800,000.

Small differences matter as much. Klarent states $8 million and a trade outlet reported 7.13 million euros. Medcast never gave a currency. We used the company's figure each time and said so.

What the money is for, and who was named as a customer

Seventy-eight items said what the money would be spent on. Six did not: Ema, Restate, Axya, EliseAI, Manus and AIBORN. Ema, Restate and Axya described a direction rather than a use, which we counted as not stated. In nine of the 78, the use of funds came only from an outlet's account and not from the company: Satlyt, Zaperon, Unveilr AI, Deepslate, Vitalize, Complaion, FRANK, Gwanak Lab and Promenaut.

Specific uses can be held against a vendor. Zeliq says "100% of the funds go into product and engineering". OneByZero listed four uses, from engineers in nine markets to a team in Japan. Pandektes said only that the money would accelerate its plan to build legal data infrastructure.

Customer evidence was thinner. Of the 84 items, 48 carried a customer, revenue, usage or results figure, and 26 named at least one customer. Seventeen did both, nine named a customer without a figure, and 27 gave a buyer neither a figure nor a name. That leaves a third of the set with nothing to call.

The 48 figures came from the company or, in a few cases, its investor. Kuro's savings of 90 hours per bid come from its lead investor. Vitalize quotes two named health-system executives, yet the item notes that neither comes with a description of how the hours or costs were measured. Healthleap's release says one Penn Medicine hospital credits it with $23.8 million a year. Santé gives growth and savings but not how many stores use it. EliseAI gives results as averages or ranges without the sample behind them. We found no confirmation in any of the 48. The nearest are Paymob's figures, which come from its investor Mubadala, and a latency benchmark that Tech.eu attributes to independent testing of Deepslate, which we did not check.

One inconsistency in our own handling is worth stating. Of the 48 items with such figures, 33 carry a red note and 15 do not. In those 15 the body attributes the figures to the company, but no note was added.

Where the first source sat: company pages, wires and investor posts

We recorded the first entry on each item's source list. In 56 items it was the company's own page, in 16 a release distributed through a wire service, in 7 an investor's post, in 4 a press report alone and in 1 an exchange notice. The four resting on press alone were Satlyt, Zaperon, Unveilr AI and Gwanak Lab, and all four carry a red note. The exchange notice was Trustly's.

The share needing a red note moves with the first source. Of the 56 items led by a company page, 30 (54%) carry a note. Of the 28 that did not start on a company page, 21 (75%) do. Wire releases account for 11 of those 21. All eight Japanese items arrived through PR TIMES, and six of the eight carry a note.

Investor posts need their own reading, because an investor has the same interest in the story as the company. Zenithon's first source was Seraphim, a participating investor and not the lead. PlannerPal's was the lead investor, Mercia, and the company's own site carried no copy. Paymob's source was Mubadala's announcement, while Wamda reported the round as co-led by Mubadala and the EBRD, a difference only a buyer who reads both would see.

By country, 26 companies were in North America, 34 in Europe, 8 in Japan, 4 in India and 6 elsewhere (Qatar, Egypt, Singapore, South Korea, China, Australia). Six items did not say where the company is based. Red notes fell on 14 of the 26 North American items, 21 of 34 European, 6 of 8 Japanese and all 4 Indian. Numbers this small describe our set and nothing wider.

What the 51 red notes said about sourcing

A red note records what we could not confirm, not wrongdoing. An item can carry more than one reason, so the counts overlap.

• 22 rest on a single source: the company's announcement alone, or press alone in four cases.
• 15 name the company's own figures as the thing we could not check.
• 13 say the stage is unstated or unconfirmed.
• 7 record two sources disagreeing: Prodoc AI's funding post says 100+ hospitals while its home page says 200+, and the others are Unveilr AI, Spotable, FRANK, Desible.ai, Namespace and Klarent.
• 7 say the amount is unstated or not a single round figure.
• 4 say no lead investor is named.
• 3 flag debt mixed with equity, 3 an investor or other third party as first source, and 3 a page with no date, among them Axya, whose letter has no date while its page metadata and BetaKit give different ones.
• 1 each: a raise not yet closed (Trustly), an amount without a currency (SimpL), investors named only by an outlet (Ampersand), a seed and Series A total with no split (Healthleap) and investors shown only as logos (Vinci).

Thirty-three items needed no note, which is not a certificate. Four items stated no stage and still carry no note: Reco, Brahma AI, Vates and Revnu. Brahma AI and Revnu say in the text that the stage is not given; the other two do not remark on it.

Questions for a freshly funded vendor, and the documents behind them

A buyer often meets the vendor days after the announcement, with contract terms still open. These seven checks come from the gaps counted above.

1. Ask what the instrument was and what part is equity. For rounds like Henry, AIONA and GMI Cloud, request the company's own description of the debt and the equity separately.

2. Ask for the use of funds in writing, and for runway in months. We did not find a stated runway in any of the 84 items. Ask for the hiring and capacity plan behind it. A promise like Zeliq's that all the money goes into product and engineering is checkable. A plan to "accelerate" is not. If the money is meant to build something, such as the modules Kuro describes as planned or the 3D features Rayon describes as upcoming, treat them as roadmap until they ship.

3. Find out who the investors are and what they do besides invest. A strategic stake does not by itself mean a reseller agreement, as the Reco item puts it about AT&T Ventures, so ask. Medcast's lead investor is a clinical software vendor, and the item suggests asking whether the relationship limits use with other vendors' systems. AIBORN's investor, Medical Data Vision, has resold its product since August 2025, so the stake follows a sales relationship. Promenaut counts HSBC as design partner and strategic investor, and HSBC's chief AI officer joins the board, which the item says means the product has so far been shaped largely around one customer. Vates says it has been profitable since 2016 and that its founders keep the majority, which changes what you ask.

4. Where a round is partly a loan, ask for the repayment schedule, any covenants, what the lender has security over, and whether a change of control triggers repayment. Henry's release gives no repayment terms. Check the vendor's latest accounts for debt service, and ask whether the lenders have a say in a sale.

5. Ask for references that match you, and for the method behind each figure: a period, a measure and a sample. Compare the vendor's own pages with its announcement. Prodoc AI's two customer counts differ, so ask which is current.

6. Ask what happens to price. None of the announcements we read promised a price hold. Rayon's and Namespace's do not mention any change, and Namespace is putting the money into data centres. Deepslate advertised a promotional rate of 2 cents per minute to mark its round, so ask whether it ends and what the standard rate is. Request a price hold, a renewal cap and notice of changes. After an acquisition alongside a raise, as with Supabase, also ask how two products will be priced together.

7. Match the name on the contract to the company that raised the money. Ascerta was Pay-i, Polygrade was ProPay and Verda was DataCrunch. Desible.ai operates under the registered name Basal Analytics, and TODAY is registered as UseToday ApS. Check that the legal entity, the data processing agreement and any security attestation all name the same company, and read the change-of-control clause.

What 84 items cannot tell you

The set is 84 funding-news items published on TrustList between 2 and 9 October 2026. The announcements behind them run from 21 September to 9 October. We chose what to cover, and our bar excludes crypto, hardware, consumer products, lending and defence. Nothing here describes funding in general.

Counts are of items, not of distinct rounds. The same Fleuret round appears twice: one item built from the company's announcement and a second item that names customers where the first names only sectors. Both are counted.

The coding was done by reading each item and its source list, not by checking filings or contacting companies. "Not stated" means the item did not say it. "Confirmed" means the item records someone outside the company and its investors vouching for a figure. We did not look beyond what each item cites, so the empty confirmation row says what our items contain, not that no confirmation exists.

Red notes were read as they stood on 9 October. We remove a note when we can confirm the point, so a repeat count would differ. The "lead or sole investor" row counts an only investor as a lead, which covers five items and Trustly's two commitment providers.

Related on TrustList:

• Only 2 of 47 software deals we covered addressed customer contracts
• Supplier management software in 2026: a buyer's guide